Measuring the Beat: 57 Stocks Surpassing Earnings Expectations
Academic research has consistently found that corporate earnings surprises cluster around small positive values, rather than large outperformance.
Posts Tagged ‘NASDAQ:VCYT’
Veracyte (VCYT) Rises with Upward Guidance Revision and Earnings Beat
Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Small Cap Growth Fund”. A copy of the letter can be downloaded...
Veracyte, Inc. (NASDAQ:VCYT) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Veracyte, Inc. first quarter 2026 financial results webcast call.
Veracyte, Inc. (NASDAQ:VCYT) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Fourth Quarter 2025 Financial Results Webcast.
Does Veracyte (VCYT) Offer Both Strength and Opportunity?
Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small Company Fund”. A copy...
UBS Reaffirmed Buy Rating on Veracyte (VCYT) After Strong Q4 Testing Revenue
Veracyte, Inc. (NASDAQ:VCYT) ranks among the best innovative stocks to buy according to Wall Street analysts. On January 12, UBS reaffirmed its Buy rating for Veracyte, Inc.
13 Best Innovative Stocks to Buy According to Wall Street Analysts
Innovation is entering a new phase of rapid acceleration, according to ARK Invest.
Veracyte, Inc. (VCYT) Sees Analyst Support as Guggenheim Reaffirms Buy Rating
TheFly reported on January 5 that Guggenheim analyst Subbu Nambi raised the price target for VCYT to $50 from $45, maintaining a Buy rating on the stock.
15 High Growth Mid-Cap Stocks to Buy
The US stock market is shifting as President Trump reinforces his “America First” agenda through subsidies and incentives aimed at boosting domestic manufacturing.
Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT)
The Fly reported on December 2, 2025, that Morgan Stanley began covering Veracyte, Inc. (NASDAQ:VCYT) with an Underweight rating and a price target of $48, up from $40.
12 Best Genomics Stocks to Invest In
Companies that study DNA to improve people's lives are known as genomics stocks.
Veracyte, Inc. (NASDAQ:VCYT) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Third Quarter 2025 Financial Results Conference Call.
Do You Believe in the Upside Potential of Veracyte (VCYT)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Veracyte, Inc. (NASDAQ:VCYT) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Second Quarter 2025 Financial Results Webcast.
Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion
Veracyte grew its share price by 7.04 percent on Friday to close at $25.25 apiece following announcements that it was set to join the S&P SmallCap 600 beginning on Tuesday, July...
Veracyte (VCYT) Fell Despite Reporting Revenue Growth and Improved Profitability
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” first quarter 2025 investor letter.
Veracyte (VCYT) Shares Pulled Back Despite Beating Expectations
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Veracyte, Inc. (NASDAQ:VCYT) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Veracyte First Quarter 2025 Financial Results Webcast.
9 AI News and Ratings on Investors’ Radar
According to a Reuters report posted on March 25, Chinese AI firms have made significant progress in closing the technology gap with the U.S., with some areas now only three months...
Veracyte (VCYT) Surged on Reporting Strong Earnings
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Veracyte, Inc. (NASDAQ:VCYT) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Fourth Quarter and Full Year 2024 Financial Results webcast.
Veracyte (VCYT) Shares Rebounded in Q3
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Veracyte, Inc. (NASDAQ:VCYT) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Third Quarter 2024 Conference Call.
Here’s Why Baron Discovery Fund Increased its Holdings in Veracyte (VCYT)
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Veracyte, Inc. (NASDAQ:VCYT) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Veracyte Second Quarter 2024 Financial Results Call. At this time, all participants are in a listen-only mode.
Veracyte (VCYT) Fell Due to a Lack of Rising Profitability
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to the Veracyte First Quarter 2024 Financial Results Conference Call.
What Makes Veracyte (VCYT) a Lucrative Investment?
Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Strategy” fourth-quarter investor letter.
Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript
Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.07. Veracyte, Inc.
Veracyte, Inc. (NASDAQ:VCYT) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Third Quarter 2023 Financial Results Webcast.
16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood’s Portfolio
In this article, we will take a look at the 16 best stocks to buy and hold for the next 15 years according to Cathie Wood's portfolio.
Veracyte, Inc. (NASDAQ:VCYT) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Second Quarter 2023 Financial Results Conference Call. [Operator Instructions].
Veracyte, Inc. (NASDAQ:VCYT) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Veracyte First Quarter 2023 Financial Results Webcast. At this time, all participants are in listen-only mode.
Veracyte, Inc. (NASDAQ:VCYT) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Veracyte Fourth Quarter and Full Year 2022 Financial Results Webcast.
4 Cheap Stocks to Buy According to Cathie Wood
In this article, we discuss the 5 cheap stocks to buy according to Cathie Wood.
Cathie Wood’s Top 15 Small-Cap Stock Picks
In this article, we discuss the 10 small-cap stock picks of Cathie Wood’s 2022 portfolio.
5 Small-Cap Growth Stocks in Cathie Wood’s Portfolio
In this article, we discuss 5 small-cap growth stocks in Cathie Wood's portfolio.
10 Small-Cap Stocks to Buy According to Ken Fisher
In this article, we discuss 10 small-cap stocks to buy according to Ken Fisher.
Hedge Fund and Insider Trading News: Axon Capital, AlphaTrAI, Lone Pine Capital, Point72 Asset Management, Inclusive Capital, Veracyte Inc (VCYT), Talos Energy Inc. (TALO), and More
A US hedge fund is braving this year’s sharp decline in the value of cryptocurrencies to launch two investment strategies aimed at reducing the volatility inherent in digital...
3 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital
In this article, we will discuss the top 3 stocks to buy according to Devesh Gandhi’s SilverArc Capital.
Cathie Wood’s 2022 Portfolio: 5 Small-Cap Stock Picks
In this article, we discuss the 5 small-cap stock picks of Cathie Wood's 2022 portfolio.
Cathie Wood’s 5 Stock Picks for the Next 5 Years
In this article, we discuss Cathie Wood's 5 stock picks for the next 5 years.
Is Veracyte Inc (VCYT) A Good Stock To Buy?
In this article we will take a look at whether hedge funds think Veracyte Inc (NASDAQ:VCYT) is a good investment right now.
Hedge Funds Are Piling Into Veracyte Inc (VCYT)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Should You Maintain Your Veracyte (VCYT) Position?
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can ...
Artisan Partners: “Veracyte (VCYT) is Well-Positioned to Expand Internationally”
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ second quarter 2021 investor letter – a copy of which can be downloaded...
Is Veracyte (VCYT) A Good Stock To Buy Now?
Baron Discovery Fund recently published its second-quarter commentary – a copy of which can be downloaded here.
Is Veracyte Inc (VCYT) Going to Burn These Hedge Funds?
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting period.
10 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 10 best pharmaceutical stocks to buy according to Cathie Wood.
Hedge Fund Resource Center
